Who
Maria Sainz
Director
Company insider
Files Form 4 as: Director, Pulse Biosciences; President and CEO, Hyperfine; Director, Shockwave Medical; Director, Atrion; Director, Avanos Medical; Director, Orthofix Medical; Director, Iridex; Director, ClearPoint Neuro.
In numbers
- Trades disclosed
- 80
- Buys
- 5
- Sells
- 3
- Bought
- $44K
- Sold
- $524K
- Companies
- 9
- Companies where not an officer
- 8
- First trade
- 19 Jun 2008
- Last trade
- 11 Jun 2026
- Last filed
- 15 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 11 Jun 2026filed 15 Jun 2026 | PLSE Pulse Biosciencesoption or derivative · Medical Devices | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 11 Jun 2026filed 15 Jun 2026 | PLSE Pulse Biosciencesoption or derivative · Medical Devices | SEC FORM 4 Code A | —3,793 at $0.00 | filing |
| 11 Jun 2026filed 15 Jun 2026 | PLSE Pulse Biosciencesoption or derivative · Medical Devices | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 11 Jun 2026filed 15 Jun 2026 | PLSE Pulse Biosciencesoption or derivative · Medical Devices | SEC FORM 4 Code A | —3,793 at $0.00 | filing |
| 31 Mar 2026filed 1 Apr 2026 | HYPR HyperfineMedical Devices | SEC FORM 4 Code A | —750,000 at $0.00 | filing |
| 31 Mar 2026filed 1 Apr 2026 | HYPR HyperfineMedical Devices | SEC FORM 4 Code A | —750,000 at $0.00 | filing |
| 5 Feb 2026filed 6 Feb 2026 | PLSE Pulse Biosciencesoption or derivative · Medical Devices | SEC FORM 4 Code A | —3,104 at $0.00 | filing |
| 5 Feb 2026filed 6 Feb 2026 | PLSE Pulse Biosciencesoption or derivative · Medical Devices | SEC FORM 4 Code A | —3,104 at $0.00 | filing |
| 8 Jan 2026filed 6 Feb 2026 | PLSE Pulse Biosciencesoption or derivative · Medical Devices | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 8 Jan 2026filed 6 Feb 2026 | PLSE Pulse Biosciencesoption or derivative · Medical Devices | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 31 May 2024filed 31 May 2024 | Shockwave Medical | SEC FORM 4 Code D | —5,328 | filing |
| 28 Mar 2024filed 28 Mar 2024 | HYPR Hyperfineoption or derivative · Medical Devices | SEC FORM 4 Code A | —1,435,000 | filing |
| 13 Jun 2023filed 15 Jun 2023 | Shockwave Medical | SEC FORM 4 Code A | —736 at $0.00 | filing |
| 23 Feb 2023filed 24 Feb 2023 | Shockwave Medical | SEC FORM 4 Sold | $140K724 at $193.00 | filing |
| 14 Dec 2022filed 14 Dec 2022 | HYPR HyperfineMedical Devices | SEC FORM 4 Bought | $4,7505,000 at $0.95 | filing |
| 9 Dec 2022filed 12 Dec 2022 | HYPR HyperfineMedical Devices | SEC FORM 4 Code A | $11K12,425 at $0.85 | filing |
| 9 Dec 2022filed 12 Dec 2022 | HYPR HyperfineMedical Devices | SEC FORM 4 Bought | $11K12,425 at $0.85 | filing |
| 8 Dec 2022filed 12 Dec 2022 | HYPR HyperfineMedical Devices | SEC FORM 4 Bought | $2,1372,575 at $0.83 | filing |
| 8 Dec 2022filed 8 Dec 2022 | HYPR HyperfineMedical Devices | SEC FORM 4 Code A | $2,1372,575 at $0.83 | filing |
| 31 Oct 2022filed 1 Nov 2022 | HYPR Hyperfineoption or derivative · Medical Devices | SEC FORM 4 Code A | —3,175,000 | filing |
News
Brainsway (NASDAQ:BWAY) vs. Orthofix Medical (NASDAQ:OFIX) Critical ComparisonOFIX · themarketsdaily.com · 25 Oct 2026Analyzing Orthofix Medical (NASDAQ:OFIX) and SeaStar Medical (NASDAQ:ICU)OFIX · themarketsdaily.com · 23 Oct 2026ClearPoint Neuro to Announce Third Quarter 2026 Results October 28, ...CLPT · pr-inside.com · 14 Oct 2026Critical Review: Beta Bionics (NASDAQ:BBNX) vs. Hyperfine (NASDAQ:HYPR)HYPR · dailypolitical.com · 14 Oct 2026
0 headlines in the last 90 days name Maria Sainz; 4 articles from the last 14 days about the 3 companies they traded most, at most three about any one of them.